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INTRODUCTION
Allergic rhinitis (AR) is one of the world's most common chronic illnesses among children and young adults, and its prevalence is estimated to range from approximately 10% to 50%. 1 Because its prevalence has risen markedly over the last few decades, there is concern regarding its economic impact compared to other chronic diseases. 2 The rapid increase in prevalence may be due to lifestyle and environmental factors rather than genetic factors. In particular, changes in dietary patterns may play a role, including decreased intake of fresh fruit, vegetables, and fish and increased intake of high-fat foods. 3 These dietary changes and the related increase in allergic diseases may be associated with reduced intake of the antioxidant vitamins C, E, and β-carotene. 4 Several epidemiological studies have investigated the effects of vitamin A (VA) on asthma, but the findings have been mixed. For example, some studies have reported that dietary VA intake and VA concentrations in the serum are significantly lower in patients with asthma than in healthy control subjects or in patients with severe asthma than in those with mild asthma. [5] [6] [7] However, other studies have reported no such associations between AR and VA. 8, 9 VA is composed of retinol and more than 600 carotenoids (e.g., β-carotene, β-cryptoxanthin, lutein-zeaxan-thin, and lycopene). 10 Among these various forms of VA, all-trans retinoic acid (ATRA) is a biologically active metabolite of VA. 11, 12 VA and retinoic acid (RA) generally promote differentiation into Th2 cells and increase the ratio of Th2 cytokines relative to Th1 cytokines by reducing the Th1 response. 13 Furthermore, RA suppresses Th17 cells and induces regulatory T cells that are important for maintaining immune homeostasis and preventing the induction of autoimmune T cells. 13, 14 However, the role of ATRA in AR after allergic challenge has not
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http://e-aair.org been well investigated. In the present study, we investigated whether ATRA alters the T-cell response to modulate the severity of airway inflammation in a Der f-induced allergic mouse model.
MATERIALS AND METHODS

Experimental animals
Forty 6-week-old, healthy female BALB/c mice (20-30 g ) were used in the present study. The experiment was performed with the approval of the Institutional Animal Care and Use Committee at the Catholic University of Korea.
Reagents
Dermatophagoides farinae (Der f) crude body extract (Arthropods of Medical Importance Resource Bank, College of Medicine, Yonsei University, Seoul, Korea) was used as the allergen. It was solubilized and stored at -70°C, and dissolved in aluminium potassium sulfate (2 mg/mL for intraperitoneal injections). ATRA (Sigma-Aldrich, St Louis, MO, USA) was stored at -20°C and protected from light until used. It was dissolved in soybean oil (3 mg/mL for intraperitoneal injections) prior to use. 15, 16 Sensitization, airway challenge, and treatment
For the allergy mouse model, we followed our previous laboratory studies. 17, 18 Forty mice were sorted into 4 groups: the control (CON, n=10), Der f (AR, n=10), all-trans retinoic acid (ATRA, n=10), and steroid (ST, n=10) groups. Allergen sensitization and challenge for the development of the AR mouse model are summarized in Fig. 1 . Briefly, on days 1 and 8, all mice except those in the control group were immunized by intraperitoneal injection of 100 µg of Der f dissolved in 80 µL of aluminum potassium sulfate for sensitization. These mice were challenged intranasally with 20 µg of Der f in a volume of 20 µL of PBS for 7 consecutive days until the day prior to the end of the experiment. The control group received phosphate-buffered saline intranasally instead of Der f. Mice in the ATRA group received intraperitoneal injections of 500 µg of ATRA. ATRA were administered intraperitoneally every other day until the day prior to the end of the experiment as follows: days 0, 2, 4, 6, 8, 10, 12, 14, 16, 18 , and 20. 15, 16 The mice in the CON, AR, and ST groups were injected with the same volume of soybean oil. The ST group received 20 of µg ciclesonide intranasally on days 18, 19, and 20.
Evaluation of allergic symptoms induced after allergen challenge
The numbers of sneezing and nose-rubbing motions during the 15-min period after the last allergen challenge were recorded and compared between the experimental groups by observers blinded to the experimental groups.
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Nasal mucosal tissue evaluation
Four mice each of the 4 groups were sacrificed and decapitated 24 hours after the last allergen challenge. The heads were fixed in 4% paraformaldehyde for 3 days at 4°C, washed in running water, decalcified for 3 days with Calci-Clear Rapid (National Diagnostics, Atlanta, GA, USA) at room temperature, dehydrated by passage through a graded alcohol series, and embedded in paraffin block. The blocks were cut into 4-µm-thick sections and stained with hematoxylin and eosin to evaluate the general morphology and number of eosinophils in the lamina propria of the nasal mucosa. The average number of cells was counted in 4 areas around the nasal septa in 50×50-µm areas under a light microscope (×200). The individual who counted eosinophils was blinded to the animals' group assignments.
Measurement of the Der f-specific level of immunoglobulin E in the serum
The Levels of Der f-specific immunoglobulin E (IgE) in the serum were measured using an enzyme-linked immunosorbent assay kit (ELISA; Bethyl, Montgomery, TX, USA) and samples were collected 24 hours after the last Der f challenge.
Cytokines and transcription factors in nasal mucosal tissue
Six mice each of the 4 groups were sacrificed to evaluate allergic reactions. Using cytokines of nasal mucosal tissue, interferon (IFN)-γ for the T helper 1 (Th1) immune reaction, interleukin (IL)-4 for the T helper 2 (Th2) immune reaction, interleukin (IL)-17 for the T helper 17 (Th17) immune reaction, and interleukin (IL)-10 and TGF-β for the regulatory T cell immune reaction were measured by real-time polymerase chain reaction (PCR). Simultaneously, the relative mRNA expression of the transcription factors T-bet, GATA-3, ROR-γt, and Foxp3 was measured by real-time PCR.
Total RNA was extracted from nasal mucosal tissue using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA), and the first strand was reverse-transcribed using random primers (TaKaRa, Otsu, Japan). The oligonucleotide primer sequences used were as follows (listed as forward primer, reverse primer): IFN-γ: 5´-AGAGCCAGATTATCTCTTTCTACCTCAG-3´, 5´-CCTTTTT CGCCTTGCTGTTG-3´; IL-4: 5´-TCAACCCCCAGCTAGTT-GTC-3´, 5´-AAATATGCGAAGCACCTTGG-3´; IL-17: 5´-TTTA- ACTCCCTTGGCGCAAAA-3´, 5´-CTTTCCCTCCGCATTGA CAC-3´; IL-10: 5´-ATGCTGCCTGCTCTTACTGACTG-3´, 5´-CCCAAGTAACCCTTATCCTGC-3´; TGF-β: 5´-CACCATCCAT-GACATGAACC-3´, 5´-TCATGTTGGACAACTGCTCC-3´; T-bet: 5´-GCCAGGGAACCGCTTATA-3´, 5´-CCTTGTTGTTGGTGA GCTTTA-3´; GATA-3: 5´-CTGGATGGCGGCAAAGC-3´, 5´-GTGGGCGGGAAGGTGAA-3´; ROR-γt: 5´-ACCTCCACTGC-CAGCTGTGTGCTGTC-3´, 5´-TCATTTCTGCACTTCTGCATG-TAGACTGTCCC-3´; Foxp3: 5´-GAAAGCGGATACCAAATGA-3´, 5´-CTGTGAGGACTACCGAGCC-3´; glyceraldehyde 3-phosphate dehydrogenase (GAPDH): 5´-GCACAGTCAAGGCC-GAGAAT-3´, 5´-GCCTTCTCCATGGTGGTGAA-3´. The levels of mRNA expression of IFN-γ, IL-4, IL-17, IL-10, TGF-β, T-bet, GATA-3, ROR-γt, Foxp3, and GAPDH were determined by realtime PCR using the ABIPRISM 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) and SYBR Green PCR master mix (TaKaRa). Their levels of expression were analyzed using the ABI 7300 Sequence Detection System (Applied Biosystems). The results were normalized relative to GAPDH expression and shown as the absolute level of mRNA expression in cytokine factors and the fold increase over the expression of the control group in transcriptional factors. 20 
Western Blotting
Western blot analysis was used to detect the relative protein expression patterns of transcription factors (T-bet, GATA-3, ROR-γt, and Foxp3) and cytokines (IFN-γ, IL-4, IL-17, IL-10, and TGF-β) within the nasal mucosa of the CON, AR, ATRA, and ST groups. The results were based on a grade of grayscale (Santa Cruz Biotechnology, Dallas, TX, USA).
Flow cytometry
For 
Statistical analysis
All measured parameters are expressed as median value (lower quartile, upper quartile). Differences among the groups were analyzed using the Kruskal-Wallis test (PASW Statistics 18; SPSS Inc., Chicago, IL, USA). In all analyses, a P value of less than 0.05 was deemed to indicate statistical significance.
RESULTS
Evaluation of allergic symptoms induced after allergen challenge
We investigated the number of sneezing and nose-rubbing motions during the 15-minute period after the last allergen challenge. The number of sneezing motion was 2 (1.75, 3) in the CON group, 16 (11.25, 19 .75) in the AR group, 7.5 (6.25, 9.75) in the ATRA group, and 9 (7, 11) in the ST group. The number of nasal rubbing motion was 10.5 (8.75, 16) in the CON group, 108.5 (101.25, 114.75) in the AR group, 54 (38.5, 63.75) in the ATRA group, and 65 (60, 76) in the ST group. The number of sneezing motion was significantly lower in the CON group than in the ATRA group (P=0.003, Fig. 2A ), whereas the number of sneezing motion was significantly higher in the AR group than The number of sneezing motion was significantly higher in the AR group than in the ATRA group. The number of nasal rubbing motion was higher in the AR group than in the ATRA group. Control group; CON, Dermatophagoides farina group; AR, all-trans retinoic acid group; ATRA, steroid group; ST. *P<0.05, ATRA vs CON; **P<0.05, ATRA vs AR according to Kruskal-Wallis tests.
http://e-aair.org in the ATRA group (P=0.001, Fig. 2A ). The number of nasal rubbing motion was also lower in the CON group than in the ATRA group (P=0.003, Fig. 2B ), whereas it was higher in the AR group than in the ATRA group (P=0.001, Fig. 2B ). Fig. 3A shows eosinophil infiltration in the lamina propria. Black arrows indicate infiltration of eosinophils in the lamina propria. Fig. 3B shows eosinophil Fig. 3B ), whereas no difference was noted between the ATRA and ST groups (P=1, Fig. 3B ).
Nasal mucosal tissue evaluation
Level of Der f-specific IgE in the serum
The level of Der f-specific IgE in the serum was significantly higher in the AR group 
Real-Time PCR and Western blot analyses
The mRNA expression levels of cytokines (IFN-γ, IL-4, IL-17, IL-10, and TGF-β) and the relative mRNA expression levels of transcription factors (T-bet, GATA-3, ROR-γt, and Foxp3) were measured by real-time PCR. Concurrently, the protein expression patterns of the cytokines and transcription factors were evaluated by Western blotting.
In the Th1 response, the relative level of mRNA of the transcription factor T-bet showed no significant difference between the groups (Fig. 5A) . The expression level of IFN-γ mRNA was significantly lower in the AR groups than in the ATRA group (P<0.001, Fig. 5B) . However, the level was not significantly different between the ATRA and ST groups (P=0.367; Fig. 5B ).
In the Th2 response, the relative level of GATA-3 mRNA was significantly higher in the AR group than in the ATRA group (P<0.001 , Fig. 6A) ; however, no significant difference in the relative GATA-3 mRNA level was found between the ATRA and ST groups (P=0.664; Fig. 6A ). The expression level of IL-4 mRNA was also significantly higher in the AR group than in the ATRA group (P=0.031, Fig. 6B) ; however, the levels were not signifi- cantly different between the ATRA and the ST groups (P=1; Fig.  6B ).
In the Th17 response, the relative level of ROR-γt mRNA was significantly higher in the AR group than in the other groups (CON, P=0.027; ATRA, P=0.046; ST, P=0.049; Fig. 7A) ; no significant difference was found between the ATRA and-the ST groups (P=1; Fig. 7A ). In addition, the level of IL-17 mRNA showed no significant difference between the groups (Fig. 7B) .
For the regulatory T (Treg) cell response, we evaluated the mRNA expression levels of Foxp3, IL-10, and TGF-β. The relative expression levels of Foxp3 were significantly lower in the AR group than in the ATRA group (P=0.028; Fig. 8A ), but no significant difference was found between the other groups. The expression level of IL-10 mRNA was also significantly lower in the AR group than in the ATRA group (P<0.001, Fig. 8B ), with no significant differences between the ATRA and the ST groups (P=1.00; Fig. 8B ). The level of TGF-β was significantly lower in the AR group than in the ATRA group (P =0.005; Fig. 8C ), whereas the other groups showed no significant differences between them (CON, P=0.109; ST, P=0.077; Fig. 8C ). We used Western blotting to double check the express patterns of the above cytokines and transcription factors, which were found to be similar to those observed for the mRNA expression levels (Fig. 9) . Because we did not performed quantified examination, we check the general grayscale patterns of each factor. The expression patterns of Foxp3 in the-ST group were different from the mRNA expression level of PCR. The results were normalized relative to GAPDH expression. In the Th2 response, the relative level of GATA-3 mRNA was higher in the AR group than in the ATRA group. The expression level of IL-4 mRNA was also higher in the AR group than in the ATRA group. Other abbreviations as in Fig. 2 . Box and whiskers plot show median and interquartile range. *P<0.05, ATRA vs CON; **P<0.05, ATRA vs AR.
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DISCUSSION
AR is the sequential response of the immune system to external antigens or allergens. The allergic response includes immune cell sensitization, migration to tissues, survival, and reactivation, followed by the execution of immune-cell effector functions that lead to the establishment of chronic inflamma- tion. 21 Healthy and allergic individuals exhibit the 3 allergenspecific T-cell subtypes-Th1, Th2, and Treg-in different proportions. A change in the dominant subset and the balance between Th2 and Treg cells might lead to either allergy development or recovery. 22 VA has been shown to modulate Th1/Th2 responses in vivo, [11] [12] [13] and VA function is mediated by antigen-presenting cells through specific intracellular receptors (RAR and RXR) that are present in the immune cells. 23, 24 However, how RA influences Th1/Th2 development in naïve T cells remains unclear. ATRA binds well to RAR, but not to RXR. 23, 24 In previous experimental studies, animals or isolated naïve T cells treated with appropriate stimuli in the presence of RA have generally expressed higher levels of Th2-associated genes and have produced higher amounts of Th2 cytokines, such as IL-4. 23, 25 Conversely, RA-treated immunized mice show downregulation of Th1 cytokines. 26 Regarding Treg cells, RA is a critical factor that provides signals for their differentiation. 27, 28 Treg cell differentiation increases in the presence of TGF-β and adequate amounts of RA. Furthermore, Foxp3 can directly bind to and inhibit the transcriptional activity of RORα and RORγt through protein-protein interactions, 29 aiding in the induction of Treg cells.
Epidemiologic studies have reported controversial results regarding the effects of VA on allergic disease. Some studies showed that VA intake/VA concentrations in the serum are lower in patients with asthma than in healthy controls and in patients with severe asthma than in those with less severe asthma, 5, 6 with the levels of β-carotene in the serum showing no difference between the groups. 6 one study reported consistent results that serum β-carotene is significantly associated with a lower risk of prevalent asthma. 30 Another found that the risk of childhood asthma was increased by lower serum levels of vitamin C and carotenoids, including α-carotene, β-carotene, and β-cryptoxanthin, and that low vitamin C and α-carotene levels continue to be predictive of asthma, whereas β-carotene is eliminated from the model. 31 In contrast, the Dutch MORGEN crosssectional intervention study reported that dietary β-carotene intake is not associated with the prevalence of symptoms but positively associated with the forced expiratory volume in 1 second and forced vital capacity. 32 A Korean epidemiologic study dem- http://e-aair.org onstrated no association between AR and α-carotene or β-carotene. 8 In that study, the sum of the measured carotenoids is reported to be significantly negatively associated with AR and not significantly associated with allergic sensitization. 9 Another study reported no relationship between VA or retinol with or without supplements and the risk of asthma. 33 In the present study, using an allergy mouse model, we designed 2 control groups: the AR group that received general sensitization and local challenge and the ST group that received the same sensitization and local challenge but received steroid treatment intranasally. In the preliminary study, we administered 500 µg of ATRA every other day according to the previous study. 15 However, since the mice treated with 5,000 µg of ATRA showed having irritability and weight loss, we decided just to administer 500 µg of ATRA every other days in the present study. 34 We demonstrated that the administration of ATRA modulated Der f-induced AR by decreasing the levels of Th2 cytokines (IL-4) and increasing Treg cytokines (IL-10, TGF-β). ATRA mediated this response by inhibiting GATA-3 and ROR-γt expression and promoting Foxp3 expression. The same trend was noted regarding protein expression in Western blot analysis. In addition, using flow cytometry, we confirmed that the expression of CD4 + CD25 +
Foxp3
+ T cells was higher in the ATRA group than in the AR group. Moreover, the tissue eosinophil counts and Der f-specific IgE levels were suppressed in the ATRA and ST groups. These data suggest that ATRA decreases the allergic response by inhibiting the activity of Th2 and activating the Treg pathway.
Our study has some limitations. Since the role of TGF-β in allergic inflammatory upper airway disease remains highly controversial, this cytokine can stimulate cellular growth, differentiation, migration, and other cytokine production, but can also inhibit these processes. However, since TGF-β at least promotes the differentiation of Treg cells that is potentiated by RA, we excluded proinflammatory effect of TGF-β. We cannot exclude the possibility of ATRA dose-dependent Treg cell expression, either. 27 Further studies are needed to identify co-stimulation factors that influence the expression of Treg cells.
In conclusion, our results suggest that ATRA may have an anti-allergic effects in an AR model and that its mechanisms of action could mainly include the induction of Treg cells and the inhibition of Th2 responses.
